Genomic alterations are associated with response to aromatase inhibitor therapy for ER-positive postmenopausal ductal carcinoma in situ: (CALGB 40903, Alliance).
| Publicado en: | Breast Cancer Research Vol. 27; no. 1; pp. 1 - 12 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
BioMed Central
2/20/2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=183174574&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 183174574 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14655411 8UYJ jtl: Breast Cancer Research issn: 14655411 maglogo: N pubinfo: dt: 2/20/2025 vid: 27 iid: 1 pid: 24147 pub: BioMed Central artinfo: ui: 183174574 10.1186/s13058-025-01963-5 183174574 ppf: 1 ppct: 11 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Genomic alterations are associated with response to aromatase inhibitor therapy for ER-positive postmenopausal ductal carcinoma in situ: (CALGB 40903, Alliance). aug: au: Marks, Jeffrey R. Zhang, Dadong Hardman, Timothy Chen, Yunn-yi Hall, Allison Simpson, Lunden Hieken, Tina Bedrosian, Isabelle Price, Elissa Sheng, Jeff Dai, Yanwan Lee, Marissa Sibley, Alexander B. Owzar, Kouros Hwang, E. Shelley affil: https://ror.org/00py81415 Department of Surgery, Duke University School of Medicine, 465 Seeley Mudd Building, 27710, Durham, NC, USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|